Subscribe to RSS
DOI: 10.1055/s-0030-1260247
Synthesis of Precursors for ¹8F-Labeling of Folic Acid for PET Application
Publication History
Publication Date:
29 September 2011 (online)
Abstract
Radiolabeled folate derivatives have the potential to target folate receptor-positive tumor cells for noninvasive diagnosis via positron emission tomography (PET) and single photon emission computed tomography (SPECT). We report the regiospecific synthesis of N ²-(N,N-dimethylaminomethylene)-2′-nitrofolic acid di-tert-butyl ester (13) and N ²-(N,N-dimethylaminomethylene)-N ¹0-formyl-2′-nitrofolic acid dimethyl ester (25), which are precursors for the radiolabeling of folic acid with the PET isotope ¹8F. A modular synthetic strategy was applied: Fmoc- and Boc-protected 4-amino-2-nitrobenzoic acid were linked via amide bonds to di-tert-butyl l-glutamate and dimethyl l-glutamate, respectively, to form building blocks 10 and 19. After Fmoc and Boc removal, both compounds were coupled to 6-(bromomethyl)pterin hydrobromide to give crude 2′-nitrofolic acid di-tert-butyl ester and 2′-nitrofolic acid dimethyl ester. After formylation of 2′-nitrofolic acid dimethyl ester at N¹0 and the introduction of an N,N-dimethylaminomethylene group at N², precursor 25 was obtained in an overall yield of 3%. The analogous 2′-fluoroderivative 28 was obtained in 7% overall yield from 4-amino-2-fluorobenzoic acid. Precursor 13 was obtained from 2′-nitrofolic acid di-tert-butyl ester in 6% yield after N²-protection. The synthesis of the reference materials 2′-nitro- and 2′-fluorofolic acid was achieved by the reaction of N-(4-amino-2-nitrobenzoyl)- and N-(4-amino-2-fluorobenzoyl)-l-glutamic acid with 6-(bromomethyl)pterin hydrobromide, giving 7% and 14% overall yield, respectively.
Key words
nucleophilic substitution - halides - amino acids - protecting groups
-
2a
Weitmann SD.Lark RH.Coney LR.Fort DW.Frasca V.Zurawski VR. Cancer Res. 1991, 52: 3396 -
2b
Parker N.Turk MJ.Westrick E.Lewis JD.Low PS.Leamon CP. Anal Biochem. 2005, 338: 284 - 3
Sega EI.Low PS. Cancer Metastasis Rev. 2008, 27: 655 - 4
Leamon CP.Reddy JA. Adv. Drug Delivery Rev. 2004, 56: 1127 - 5
Li S.Deshmukh HM.Huang L. Pharm. Res. 1998, 15: 1540 - 6
Cho BK.Roy EJ.Patrick TA.Kranz DM. Bioconjugate Chem. 1997, 8: 338 - 7
Leamon CP.Pastan I.Low PS. J. Biol. Chem. 1993, 268: 24847 -
8a
Low PS.Henne WA.Doornweerd DD. Acc. Chem. Res. 2008, 41: 120 -
8b
Hilgenbrink AR.Low PS. J. Pharm. Sci. 2005, 94: 2135 -
8c
Gabizon A.Shmeeda H.Horowitz AT.Zalipsky S. Adv. Drug. Delivery Rev. 2004, 56: 1177 -
9a
Mathias CJ.Lewis MR.Reichert DE.Laforest R.Sharp TL.Lewis JS. Nucl. Med. Biol. 2003, 30: 725 -
9b
Mathias CJ.Wang S.Lee RJ.Waters DJ.Low PS.Green MA. J. Nucl. Med. 1996, 37: 1003 -
10a
Müller C.Forrer F.Schibli R.Krenning EP.de Jong M. J. Nucl. Med. 2008, 49: 310 -
10b
Müller C.Dumas C.Hoffmann U.Schubiger PA.Schibli R. J. Organomet. Chem. 2004, 689: 4712 -
10c
Mindt TL.Müller C.Melis M.de Jong M.Schibli R. Bioconjugate Chem. 2008, 19: 1689 -
10d
Mindt TL.Müller C.Stuker F.Salazar J.-F.Hohn A. Bioconjugate Chem. 2009, 20: 1940 -
10e
Sparr C.Michel U.Marti RE.Müller C.Schibli R.Moser R.Groehn V. Synthesis 2009, 787 -
10f
Guo W.Hinkle G.Lee R. J. Nucl. Med. 1999, 40: 1563 -
10g
Reddy JA.Xu LC.Parker N.Vetzel M.Leamon CP. J. Nucl. Med. 2004, 45: 857 -
10h
Mathias CJ.Hubers D.Low PS.Green MA. Bioconjugate Chem. 2000, 11: 253 -
11a
Siegel BA.Dehdashti F.Mutch DG.Podoloff DA.Wendt R.Sutton GP. J. Nucl. Med. 2003, 44: 700 -
11b
Mathias CJ.Green MA. Nucl. Med. Biol. 1998, 25: 585 -
11c
Wang S.Luo J.Lantrip DA.Waters DJ.Mathias CJ.Green MA.Fuchs PL.Low PS. Bioconjugate Chem. 1997, 8: 673 -
12a
Bettio A.Honer M.Müller C.Brühlmeier M.Müller U.Schibli R.Groehn V.Schubiger AP.Ametamey SM. J. Nucl. Med. 2006, 47: 1153 -
12b
Ross TL.Honer M.Lam PYH.Mindt TL.Groehn V.Schibli R.Schubiger AP.Ametamey SM. Bioconjugate Chem. 2008, 19: 2462 -
12c
Ametamey SM,Moser R,Ross TL, andGroehn V. inventors; Patent WO2008/125617 A2. ; Chem. Abstr. 2008, 1282601 -
12d
Low PS,Varghese B, andVlahov IR. inventors; Patent WO2006/071754 A2. ; Chem. Abstr. 2006, 656863 -
13a
Haka SM.Klibourn MR.Watkins LG.Toorongian SA. J. Labelled Compd. Radiopharm. 1989, 27: 823 -
13b
Iwata R.Pascali C.Bogni A.Horvath G.Kovacs Z.Yanai K.Ido T. Appl. Radiat. Isot. 2000, 52: 87 -
13c
Angelini G.Speranza M.Wolf AP.Shiue C.-Y. J. Fluorine Chem. 1985, 27: 177 - 14
Cosulich DB.Seeger DR.Fahrenbach MJ.Collins KH.Roth B.Hultquist ME.Smith JM. J. Org. Chem. 1953, 75: 4675 - 15
Backer HJ.Houtman AC. Recl. Trav. Chim. Pays-Bas 1951, 70: 738 - 16
Ross TL.Honer M.Müller C.Groehn V.Schibli R.Ametamey SM. J. Nucl. Med. 2010, 51: 1756 -
17a
Taylor EC.Portnoy RC.Hochstetler DC.Kobayashi T. J. Org. Chem. 1975, 40: 2347 -
17b
Taylor EC.Perlmann KL.Kim Y.-H.Sword IP.Jacobi PA. J. Am. Chem. Soc. 1973, 95: 6413 -
18a
Taylor EC.Henrie RN.Portnoy RC. J. Org. Chem. 1978, 43: 736 -
18b
Taylor EC.Kobayashi T. J. Org. Chem. 1973, 38: 2817 - 19
Mautner HG.Kim Y.-H. J. Org. Chem. 1975, 40: 3447 - 20
Bader H.Rosowsky A. J. Org. Chem. 1991, 56: 3386 - 21
Baugh CM.Shaw E. J. Org. Chem. 1964, 29: 3610 -
22a
Thijssen HHW. Anal. Biochem. 1973, 54: 609 -
22b
Taylor EC.Henrie RN.Portnoy RC. J. Org. Chem. 1978, 43: 736 -
23a
Freisleben A.Schieberle P.Rychlik M. J. Agric. Food Chem. 2002, 50: 4760 -
23b
Roberts EC.Shearly YF. J. Med. Chem. 1972, 15: 1310 -
23c
Roberts EC.Shearly YF. J. Med. Chem. 1973, 16: 697 -
23d
Sletzinger M.Reinhold D.Grier J.Beachem M.Tishler M. J. Am. Chem. Soc. 1955, 77: 6365 -
23e
Roberts EC.Shearly YF. J. Med. Chem. 1974, 17: 219 -
23f
Martinelli JE.Chaykovsky M. J. Med. Chem. 1979, 22: 874 -
23g
Dueker SR.Jones AD.Smith GM.Clifford AJ. J. Labelled Compd. Radiopharm. 1995, 36: 981 -
23h
Maunder P.Finglas PM.Mallet AI.Mellon FA.Razzaque MA.Ridge B.Vehteristo L.Witthöft C. J. Chem. Soc., Perkin Trans. 1 1999, 1311 -
23i
Khalifa E.Sengupta PK.Bieri JH.Viscontini M. Helv. Chim. Acta 1976, 59: 242 -
23j
Sengupta PK.Bieri JH.Viscontini M. Helv. Chim. Acta 1975, 58: 1374 -
23k
Bieri JH.Viscontini M. Helv. Chim. Acta 1973, 56: 2905 - 24
Traub H.Pfleiderer W. Pteridines 1999, 10: 79 -
25a
Piper JR.McCaleb SG.Montgomery JA. J. Heterocycl. Chem. 1986, 24: 279 -
25b
Montgomery JA.Rose JD.Temple C.Piper J. In Chemistry and Biology of Pteridines, Proceedings of the 5th International SymposiumPfleiderer W. de Gruyter; Berlin: 1975. p.485 - 26
Curtius T.Bollenbach HFr. J. Prakt. Chem. 1907, 74: 281 - 27
Seeger DR.Cosulich DB.Smith JM.Hultquist MH. J. Am. Chem. Soc. 1949, 71: 1253 - 28
Taylor EC.Cain CK. J. Am. Chem. Soc. 1949, 71: 2538 - 29
Bodanszky A.Bodanszky M.Chandramouli N.Kwei JZ.Martinez J.Tolle JC. J. Org. Chem. 1980, 45: 72 -
30a
Takagishi G.Katsoulos G.Schlosser M. Synlett 1992, 360 -
30b
Gangjee A.Jain HD.McGuire J.Kisliuk RL. J. Med. Chem. 2004, 47: 6730 - 31
Kanai F.Kaneko T.Morishima H.Isshiki K.Takita T.Takeuchi T.Umezawa H. J. Antibiot. 1985, 38: 39 - 32
Martinez J.Laur J. Synthesis 1982, 979 - 33
Waki M.Meienhofer J. J. Org. Chem. 1977, 42: 2019 - 34
Groehn V.Moser R.Pugin B. Adv. Synth. Catal. 2005, 347: 1855 -
36a
Glaser M.Arstad E. Bioconjugate Chem. 2007, 18: 989 -
36b
Waterhouse RN.Collier TL. Nucl. Med. Biol. 1997, 24: 127 -
36c
Gründer G.Siessmeier T.Piel M.Vernaleken I.Buchholz H.-G.Zhou Y.Hiemke C.Wong DF.Rösch F.Bartenstein P. J. Nucl. Med. 2003, 44: 109
References
Current address: Radiopharmaceutical Chemistry, Institute for Nuclear Chemistry, Johannes Gutenberg-Universität Mainz, Fritz-Strassmann-Weg 2, 55128 Mainz, Germany.
35Unpublished results.